Clinical Trial

Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation

Study acronym: CAP NOVA
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these assessments. More recently, many investigators have adopted rapid local to 39°C instead, based on its larger dependency on NO and therefore improved ability to quantify NO-dependent dilation without the use of pharmacological techniques. However, to date, only one direct methodological comparison between these protocols has been performed. In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) they examine the blood vessels in a nickel-sized area of the skin in young adults ages 18 - 30 years old. Local heating of the skin at the microdialysis sites is used to explore differences in mechanisms governing microvascular control. As a compliment to these measurements, the investigators also have participants fill out a variety of surveys to assess things such as sleep quality, physical activity, daily stressors, etc.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-11; most recent amendment 2025-08-19.
Status change: Not Yet Recruiting → Recruiting 2024-09-11
Trial Details
NCT Number NCT06499844
Lead Sponsor University of Iowa
Conditions Endothelial Function
Enrollment 56 participants
Start Date 2024-08-01
Primary Completion 2025-08-12 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-24